Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
Divaka Perera, Mark C. Petrie(British Heart Foundation), James Cotton(Guy's and St Thomas' NHS Foundation Trust), Richard D. Evans(London School of Hygiene & Tropical Medicine), Pedro Saramago(University of York), Dwayne Conway(Guy's and St Thomas' NHS Foundation Trust), Holly Morgan(King's College London), Margaret McEntegart(Golden Jubilee National Hospital), Amedeo Chiribiri(King's College London), Kalpa De Silva(Guy's and St Thomas' NHS Foundation Trust), Tim Clayton(London School of Hygiene & Tropical Medicine), Richard Edwards(Freeman Hospital), James Spratt(St George's, University of London), Ruth R Canter(Guy's and St Thomas' NHS Foundation Trust), Anthony Gershlick, Peter O’Kane(Royal Bournemouth Hospital), Andrew L. Clark(University of Bedfordshire), M. J. Ryan(King's College London), Roshan Weerackody(Barts Health NHS Trust), Matthew Dodd(London School of Hygiene & Tropical Medicine), Ajay M. Shah(University of Wales), John P. Greenwood(University of Leeds), Sophie Arnold, Lana Dixon(Queen's University Belfast)
Cited by 566
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
|Proceedings of the National Academy of Sciences|2010|1.6k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k